Status:
RECRUITING
Optimizing Mango's Glycemic Impact: Investigating Mango Consumption Timing in Prediabetic Individuals
Lead Sponsor:
Clinical Nutrition Research Center, Illinois Institute of Technology
Collaborating Sponsors:
National Mango Board
Conditions:
Pre Diabetes
Eligibility:
All Genders
20-60 years
Phase:
NA
Brief Summary
The purpose of this study is to investigate the effect of mango intake on metabolic and inflammatory responses relative to meals in individuals at risk of developing diabetes, as well as to understand...
Detailed Description
The primary goal of the proposed project is to advance current knowledge about the antidiabetic and anti-inflammatory benefits of consuming mangoes, especially in individuals with prediabetes, and to ...
Eligibility Criteria
Inclusion
- Be between 20-60 years old.
- Have a BMI of 25-35 kilograms per square meter.
- Have fasting blood glucose between 100-125 milligrams per deciliter or Glycated hemoglobin (HbA1c) between 5.7-6.4%.
- Be non-smokers for at least 12 months.
- Be generally healthy, with no major organ-related diseases.
- Not take medications or supplements that could interfere with the study.
- Be able to follow study procedures, including dietary restrictions and scheduled visits.
Exclusion
- Smoke, vape, or use marijuana.
- Have allergies or intolerance to mangoes or study foods.
- Have blood pressure above 160/100 millimeters of Mercury.
- Have fasting blood glucose above 125 milligrams per deciliter.
- Have a history of major heart disease, stroke, or cancer in the past five years.
- Be pregnant, planning to become pregnant, or breastfeeding.
- Take anti-inflammatory drugs or certain dietary supplements.
- Have had major surgery or trauma in the past two months.
- Follow extreme diets (e.g., vegan, Atkins).
- Have used antibiotics in the last six weeks.
- Have a history of eating disorders or substance abuse in the past two years.
- Drink more than three cups of coffee or tea per day.
- Have donated blood in the last three months.
- Be professional athletes or do excessive exercise.
- Have had weight changes of more than 11 pounds in the past two months.
- Work overnight shifts.
Key Trial Info
Start Date :
April 14 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06986161
Start Date
April 14 2025
End Date
December 31 2026
Last Update
July 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Nutrition Research Center
Chicago, Illinois, United States, 60616